See All Slides - tctmd.com

Slides

Presentation TCT 2014

Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data

Presenter: Khusrow Niazi

September 16, 2014

Presentation TCT 2014

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Horst Sievert

September 16, 2014

Presentation TCT 2014

The Clinical SYNTAX score has an additive predictive value in high risk patients

Presenter: Jeehoon Kang

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

Improvement Of Left Ventricular Function Assessment By Global Longitudinal Strain After Successful Percutaneous Coronary Intervention For Chronic Total Occlusions

Presenter: Misato Chimura

September 16, 2014

Presentation TCT 2014

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Presenter: Gregory Wilson

September 16, 2014

Presentation TCT 2014

Tongxinluo reduces infarct size by promoting endothelial adhesion junction integrity in reperfused diabetic hearts via PPAR-? pathway

Presenter: Kang Qi

September 16, 2014

Presentation TCT 2014

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Presenter: Kazushige Kadota

September 16, 2014

Presentation TCT 2014

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

Presenter: William Wilson

September 16, 2014

Presentation TCT 2014

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Presenter: Daniel Garcia

September 16, 2014

Advertisement

Slides

Long-term Costs of Directional Atherectomy vs_ Other Treatment Choices for Diabetes Patients with Peripheral Artery Disease: a 24-Month Analysis of Administrative Claims Data

First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

The Clinical SYNTAX score has an additive predictive value in high risk patients

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Improvement Of Left Ventricular Function Assessment By Global Longitudinal Strain After Successful Percutaneous Coronary Intervention For Chronic Total Occlusions

Bipolar Radiofrequency Renal Denervation With The Vessix Balloon Catheter System: Preclinical Safety Evaluation Through 180 Days

Tongxinluo reduces infarct size by promoting endothelial adhesion junction integrity in reperfused diabetic hearts via PPAR-? pathway

Clinical Outcomes of Patients With High Risk Acute Coronary Syndrome Treated With a New Generation Drug-Eluting Stent, Ultimaster compared with Xience ? Results from CENTURY II___

Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve: The Toronto Congenital Cardiac Centre for Adults Experience

CATHETER-BASED RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION: A META-ANALYSIS OF RANDOMIZED TRIALS

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content